Plain language summary: an analysis of the safety of futibatinib treatment in people with different types of cancer.

Meric-Bernstam F, Hollebecque A, Furuse J, Oh DY, Bridgewater JA, Anderson B, Hangai N, Wacheck V, Goyal L

DOI: 10.1080/14796694.2024.2414593
Published: 2025 Jan
Container: Future oncology (London, England)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2024.2414593,
  title = {Plain language summary: an analysis of the safety of futibatinib treatment in people with different types of cancer.},
  author = {Meric-Bernstam F and Hollebecque A and Furuse J and Oh DY and Bridgewater JA and Anderson B and Hangai N and Wacheck V and Goyal L},
  year = {2025},
  journal = {Future oncology (London, England)},
  doi = {10.1080/14796694.2024.2414593},
  url = {https://doi.org/10.1080/14796694.2024.2414593}
}

RIS

TY  - JOUR
TI  - Plain language summary: an analysis of the safety of futibatinib treatment in people with different types of cancer.
AU  - Meric-Bernstam F
AU  - Hollebecque A
AU  - Furuse J
AU  - Oh DY
AU  - Bridgewater JA
AU  - Anderson B
AU  - Hangai N
AU  - Wacheck V
AU  - Goyal L
PY  - 2025
JO  - Future oncology (London, England)
DO  - 10.1080/14796694.2024.2414593
UR  - https://doi.org/10.1080/14796694.2024.2414593
ER  -

APA

F, M., A, H., J, F., DY, O., JA, B., B, A., N, H., V, W., & L, G. (2025). Plain language summary: an analysis of the safety of futibatinib treatment in people with different types of cancer.. Future oncology (London, England). https://doi.org/10.1080/14796694.2024.2414593

Source records

pubmed · retrieved 2026-09-27T15:03:40.947Z
europe-pmc · retrieved 2026-09-27T15:03:40.971Z